Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-11-007345
Filing Date
2011-11-14
Accepted
2011-11-14 15:28:15
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 c67530_10-q.htm 10-Q 276727
2 c67530_ex31-1.htm EX-31.1 8928
3 c67530_ex31-2.htm EX-31.2 8937
4 c67530_ex32-1.htm EX-32.1 3520
5 c67530_ex32-2.htm EX-32.2 3531
  Complete submission text file 0000930413-11-007345.txt   1724990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ibio-20110930.xml EX-101.INS 316594
7 ibio-20110930.xsd EX-101.SCH 10776
8 XBRL CALCULATION FILE ibio-20110930_cal.xml EX-101.CAL 18721
9 XBRL DEFINITION FILE ibio-20110930_def.xml EX-101.DEF 54100
10 XBRL LABEL FILE ibio-20110930_lab.xml EX-101.LAB 82255
11 XBRL PRESENTATION FILE ibio-20110930_pre.xml EX-101.PRE 61764
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 111201852
SIC: 2834 Pharmaceutical Preparations